VANCOUVER, British Columbia, May 16, 2018 (GLOBE NEWSWIRE) -- Body and Mind Inc. (CSE:BAMM) (US OTC:BMMJ), (the “Company” or “BAM”), a leading provider of medical and recreational cannabis in Nevada is pleased to announce the company will be attending the second annual Canaccord Genuity Cannabis Conference in New York on May 17, 2018.

Body and Mind President Robert Hasman commented, “Our experience creating and supplying top quality marijuana products and brands for the medical market has positioned us well for the rapidly growing Nevada recreational market.  Our award winning genetics, strains, edibles and extracts have been widely popular as we continually introduce new products and expand our operations.”

The conference promises to offer attendees insights into the risks and opportunities that legalization of cannabis presents. The full-day event will feature industry leaders sharing their perspectives and opinions on what social, legal, political and economic forces investors and entrepreneurs in the space will need to consider as the commercial cannabis space evolves.

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information regarding Body and Mind Inc. please contact:

Michael Mills

About Body and Mind

Body and Mind is a publicly traded company investing in high quality medical and recreational cannabis cultivation and production.  Our flagship asset in Nevada was awarded one of the first medical marijuana cultivation licences and holds medical and recreational cultivation and production licences.  Body and Mind products include flower, edibles, topicals, extracts as well as GPEN Gio cartridges.

Body and Mind marijuana strains have won awards including the Las Vegas Hempfest Cup 2016, High Times Top Ten, the NorCal Secret Cup and the Emerald Cup. Body and Mind continues to expand operations in Nevada and is constantly reviewing accretive expansion opportunities.

For more information please visit our web site at

Notice regarding Forward Looking Statements: This news release contains forward-looking statements. The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including the inability of the Company to obtain shareholder and exchange approval, or to raise additional equity as well as the various risk factors discussed in the Company's disclosure documents, which can be found under the Company's profile on Body and Mind Inc. undertakes no obligation to update publicly or revise any forward looking information, whether as a result of new information, future events or otherwise, except as required by law or the Canadian Securities Exchange. We seek safe harbour.